176 related articles for article (PubMed ID: 22121953)
21. Chromosome 8 Polysomy Accounting for MYC Over-Expression in Angiosarcoma Arising as Somatic-Type Malignancy in Metastatic Teratoma. Case Report.
Vargas AC; Grimison P; Joy C; Garrone B; Bonar F; Ghahan RM; Davidson T; Maclean FM
Int J Surg Pathol; 2022 Jun; 30(4):462-465. PubMed ID: 34955058
[TBL] [Abstract][Full Text] [Related]
22. Post-radiation vascular lesions of the breast.
Ronen S; Ivan D; Torres-Cabala CA; Curry JL; Tetzlaff MT; Aung PP; Nagarajan P; Suster S; Prieto VG
J Cutan Pathol; 2019 Jan; 46(1):52-58. PubMed ID: 30251277
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
Persons DL; Borelli KA; Hsu PH
Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
[TBL] [Abstract][Full Text] [Related]
24. Array CGH analysis identifies two distinct subgroups of primary angiosarcoma of bone.
Verbeke SL; de Jong D; Bertoni F; Sciot R; Antonescu CR; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2015 Feb; 54(2):72-81. PubMed ID: 25231439
[TBL] [Abstract][Full Text] [Related]
25. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
[TBL] [Abstract][Full Text] [Related]
26. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification.
Tajima S; Mochizuki R; Sugimura H; Hoshi S
Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854
[No Abstract] [Full Text] [Related]
27. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
[TBL] [Abstract][Full Text] [Related]
28. [Post-radiation atypical vascular lesions and angiosarcoma: 11 cases].
Karkouche R; Carbonnelle-Puscian A; Rivet J; Fraitag S; Moulonguet I; Carlotti A; Havard S; Vérola O; Cavelier-Balloy B
Ann Dermatol Venereol; 2012 Feb; 139(2):109-17. PubMed ID: 22325749
[TBL] [Abstract][Full Text] [Related]
29. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
30. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
Italiano A; Thomas R; Breen M; Zhang L; Crago AM; Singer S; Khanin R; Maki RG; Mihailovic A; Hafner M; Tuschl T; Antonescu CR
Genes Chromosomes Cancer; 2012 Jun; 51(6):569-78. PubMed ID: 22383169
[TBL] [Abstract][Full Text] [Related]
31. c-myc and cutaneous vascular neoplasms.
Feller JK; Mahalingam M
Am J Dermatopathol; 2013 May; 35(3):364-9. PubMed ID: 23221487
[TBL] [Abstract][Full Text] [Related]
32. Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma.
Patton KT; Deyrup AT; Weiss SW
Am J Surg Pathol; 2008 Jun; 32(6):943-50. PubMed ID: 18551753
[TBL] [Abstract][Full Text] [Related]
33. c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.
von Rahden BH; Stein HJ; Pühringer-Oppermann F; Sarbia M
Neoplasia; 2006 Sep; 8(9):702-7. PubMed ID: 16984727
[TBL] [Abstract][Full Text] [Related]
34. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract][Full Text] [Related]
35. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
[TBL] [Abstract][Full Text] [Related]
36. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
37. Secondary Angiosarcoma With C-MYC Amplification Following Prophylactic Bilateral Mastectomy and Autologous Breast Reconstruction: Report of a Case and Review of the Literature.
Webb C; Partain N; Koduru P; Hwang H; Sarode VR
Int J Surg Pathol; 2021 Apr; 29(2):205-210. PubMed ID: 32552130
[TBL] [Abstract][Full Text] [Related]
38. Atypical vascular lesion of the breast.
Mandrell J; Mehta S; McClure S
J Am Acad Dermatol; 2010 Aug; 63(2):337-40. PubMed ID: 20138394
[TBL] [Abstract][Full Text] [Related]
39. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
40. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.
Park K; Kwak K; Kim J; Lim S; Han S
Hum Pathol; 2005 Jun; 36(6):634-9. PubMed ID: 16021569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
